Chemotherapeutic Resistance in Egyptian Acute Myeloid Leukemia Patients

BACKGROUND: Acute Myeloid Leukemia (AML) is a heterogeneous disorder with variable genetic abnormalities and cytogenetic alterations which provide a significant disease prognosis and determine response to therapy. PURPOSE: We aim to investigate the expression of the MDR1 gene in 100 Egyptian AML pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassem, Neemat M, Medhat, Nashwa, Kassem, Hebatallah A, El-Desouky3, Mohamed A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852834/
https://www.ncbi.nlm.nih.gov/pubmed/31450916
http://dx.doi.org/10.31557/APJCP.2019.20.8.2421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852834/
https://www.ncbi.nlm.nih.gov/pubmed/31450916
http://dx.doi.org/10.31557/APJCP.2019.20.8.2421

Ejemplares similares